Abstract
We have utilized deceased donor livers to maintain low mortality on the wait list, to provide a significantly high transplant rate, and to achieve excellent graft and patient outcomes at 3 months, one year, and 3 years, surpassing the national and expected averages. We have also shown that reLT remains a durable option for patients with recurrent disease including recurrent HCV, that DCD livers continue to be a viable source of donor grafts, and that LT in patients with high BMI produces acceptable outcomes.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Body Mass Index
-
Carcinoma, Hepatocellular / surgery
-
Child
-
Child, Preschool
-
Female
-
Florida / epidemiology
-
Graft Rejection / etiology
-
Graft Rejection / mortality
-
Graft Rejection / prevention & control*
-
Graft Survival*
-
Hepatitis C / surgery
-
Humans
-
Infant
-
Infant, Newborn
-
Kaplan-Meier Estimate
-
Liver Diseases / mortality
-
Liver Diseases / surgery*
-
Liver Neoplasms / surgery
-
Liver Transplantation / adverse effects
-
Liver Transplantation / mortality
-
Liver Transplantation / trends*
-
Male
-
Middle Aged
-
Reoperation
-
Retrospective Studies
-
Time Factors
-
Tissue Donors / supply & distribution*
-
Treatment Outcome
-
Waiting Lists
-
Young Adult